Records containing: Non-alcoholic Fatty Liver Disease (NAFLD)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-19Simultaneous Quantification of Liver Fat Content, Fatty Acid Composition, and Fibrosis Using Non-invasive Breath-hold Quantitative Spin-lock MRI for Assessment of Non-Alcoholic Steatohepatitis
-
CLINICAL_TRIALS study record update · 2026-02-11A Phase 1, Open-Label Study Evaluating the Effect of Miricorilant on Hepatic Lipids in Patients With Presumed Metabolic Dysfunction-Associated Steatohepatitis (MASH)
-
CLINICAL_TRIALS study record update · 2025-12-08Assessment of Hepatic Steatosis Using Dedicated Software Implemented on Ultrasound Devices
-
CLINICAL_TRIALS study record update · 2025-12-05Non-alcoholic Fatty Liver Disease Parametric PET (FLiPP) Study
-
CLINICAL_TRIALS study record update · 2025-12-02A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG): Effects of ESG on Non-Alcoholic Steatohepatitis (NASH) and Portal Pressure Gradient in Patients With Obesity and NASH With Advanced Fibrosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-09-30Observational, Single Arm, Prospective Study to Evaluate the Effectiveness of Legalon® in Addition to Diet and Exercise in Reducing Plasma Levels of Liver Enzymes
-
CLINICAL_TRIALS study record update · 2025-09-30Effect of Substituting Plant Protein for Animal-Protein on Cardiometabolic Risk: A Series of Systematic Reviews and Meta-Analyses of Controlled Feeding Trials to Provide Evidence-Based Guidance for Nutrition Guidelines Development
-
CLINICAL_TRIALS study record update · 2025-09-15Evaluating Non-Invasive Approaches for Screening, Diagnosis, and Monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Bariatric Patients & Identifying Biomarkers for Predicting Type 2 Diabetes Remission
-
CLINICAL_TRIALS study record update · 2025-04-24Elucidating Hepatic Metabolism in Non-alcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2025-04-08The Ameliorative Effect of C-Kit (+) Hepatic Endothelial Cells With Mertk Deficiency on Nonalcoholic Steatohepatitis
-
CLINICAL_TRIALS study record update · 2025-02-10A Phase 2, Randomised, Placebo Controlled Study to Evaluate the Efficacy, Tolerability and Safety of Metabolic Cofactor Supplementation in Obese Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)
-
CLINICAL_TRIALS study record update · 2025-01-23Screening in Primary Care of Advanced Liver Fibrosis in NAFLD And/or Alcoholic Patients
-
CLINICAL_TRIALS study record update · 2024-11-14NASH Patient's Itinerary: Comparison of Strategies for Screening, Referring and Management of Diabetic Patients
-
CLINICAL_TRIALS study record update · 2024-10-10Combined Active Treatment in Type 2 Diabetes with NASH
-
CLINICAL_TRIALS study record update · 2024-10-04Effectiveness of Nutrition Education Program and Omega-3 Supplementation on Body Weight, Liver Enzymes, Lipid Profile Among Non-Alcoholic Fatty Liver Disease Patients
-
CLINICAL_TRIALS study record update · 2024-10-04Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS)
-
CLINICAL_TRIALS study record update · 2023-08-14The Effect of Acute Nutritional Challenges on FGF21 Levels in Humans
-
CLINICAL_TRIALS study record update · 2023-06-18Comparison of Steatosis and Fibrosis Measurements From Velacur and MRE/MRI-PDFF in Patients With Chronic Liver Disease
-
CLINICAL_TRIALS study record update · 2022-05-31A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Pharmacodynamic Effects of MEDI0382 in Obese Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)/ Non-Alcoholic Steatohepatitis (NASH)
-
CLINICAL_TRIALS study record update · 2022-04-04A Randomized, Double-Blinded, Placebo-controlled Phase IIa Study to Assess the Efficacy and Safety of a Novel AstraZeneca Compound in Subjects With Non-alcoholic Steatohepatitis (NASH) or Non-alcoholic Fatty Liver Disease (NAFLD)
-
CLINICAL_TRIALS study record update · 2021-05-27How Does Dietary Carbohydrate Influence the Formation of an Atherogenic Lipoprotein Phenotype?
-
CLINICAL_TRIALS study record update · 2021-02-03Association of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2020-06-30Efficacy of Nutritional Therapy With High Methionine Content in the Treatment of Non-alcoholic Fatty Liver: a Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2020-03-05Metabolic Surgery for the Treatment and Understanding of Non-Alcoholic Steato-Hepatitis (NASH): Weight-Dependent and Weight-Independent Effects
-
CLINICAL_TRIALS study record update · 2019-09-23Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease Based on Artificial Intelligence.